A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Eisai Inc.
Eisai Inc.
Sanofi
Merck Sharp & Dohme LLC
The First Affiliated Hospital of Zhengzhou University
Kyowa Kirin Co., Ltd.
Saint Petersburg State University, Russia
Assistance Publique Hopitaux De Marseille
National Medical Research Radiological Centre of the Ministry of Health of Russia
Aziende Chimiche Riunite Angelini Francesco S.p.A
University of Heidelberg Medical Center
DHR Health Institute for Research and Development
Region Skane
Mercy Research
University Health Network, Toronto
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Central Hospital, Nancy, France
Washington University School of Medicine
University of Kansas Medical Center
Taichung Veterans General Hospital
University of Copenhagen
Fox Chase Cancer Center
Maastricht University Medical Center
Khon Kaen University
Tampere University Hospital
Elesta S.R.L.
Access Pharmaceuticals, Inc.
Amgen
Copenhagen University Hospital at Herlev
National Taiwan University Hospital
University Hospital, Clermont-Ferrand
Oxford University Hospitals NHS Trust
Yonsei University
Sanofi
National Institutes of Health Clinical Center (CC)
St George Hospital, Australia
Mt. Sinai Medical Center, Miami